No products in the cart.
Vaccination boosted immunity acquired from previous SARS-CoV-2 infection
1. Two doses of the Pfizer-BioNTech BNT162b2 vaccine were linked to high immediate protection again severe acute respiratory syndrome coronary ...
Tag: SARS-CoV-2
Single-dose Ad26.COV2.S vaccine provides moderate protection against Covid-19 related outcomes
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to severe Covid-19-related infection and medical intervention. ...
BNT162b2 safe and efficacious in children 5 to 11 years of age
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11 years of ...
Adding mask recommendation did not significantly reduce the SARS-CoV-2 infection rate
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection by more than 50%. 2. ...
Fourth BNT162b2 vaccine dose provides short-term effectiveness against Covid-19 related outcomes
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of symptomatic Covid-19 infection and hospitalization compared to ...
Early ivermectin treatment does not lower Covid-19 related hospitalizations
1. Ivermectin treatment did not lower the incidence of medical admission to a hospital due to the progression of Covid-19. ...
Covid-19 vaccines and boosters are transiently effective against the Omicron
1. Two doses of BNT162b2 (Pfizer-BioNTech) and mRNA-1273 (Moderna) vaccine provided good protection against the Omicron (B.1.1.529) variant but rapidly ...
Protection against SARS-CoV-2 highest after infection-acquired immunity boosted with vaccination in health care workers
1. SARS-CoV-2 infection-acquired immunity waned after 1 year, but immune protection remained high beyond 1 year in those boosted with ...
BNT162b2 vaccination after SARS-CoV-2 infection decreases risk of recurrent infection
1. In a retrospective cohort study of individuals who recovered from SARS-CoV-2, BNT162b2 vaccination decreased the risk of recurrent infection. ...
More severe symptoms and hospitalizations seen during period of COVID-19 delta variant dominance compared to omicron
1. Loss of sense of smell was more common during a period of delta dominance, while sore throat was more ...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.